By removing the need for prior approval by ANVISA, the patent process for pharmaceutical and biotechnology products has been shortened and associated costs reduced.
IP strategy is best considered at the start of research and development (R&D). The first step is choosing the IP approach to take during product development. Mark Suddaby explains the options.
The European patent system provides companies with an efficient structure for protecting inventions in Europe. However, there are a number of crucial points to consider if they are to make the best use of the system.
Finally, some good news for the Unitary Patent. Germany's Federal Constitutional Court has rejected the two applications for a preliminary injunction against the German Act of Approval to the Unified Patent Court Agreement. The decisions mark a key step forward for the Unitary Patent, says Robert Balsters.
The proposed Unitary Patent system promised a simpler and more cost-effective route to patent protection in and across the EU member states; however, its route to implementation remains far from certain. We set out the answers to some frequently asked questions.
Novagraaf’s Department of Mechanical Engineering has provided patent services to United Caps, a manufacturer of plastic caps for the food industry, for more than 15 years. We spoke to Sébastien Rime, Director of R&D, about current challenges in the manufacturing and production of plastic caps, and how Novagraaf has been able to help.
To date, new Guidelines for Examination have been published by the European Patent Office (EPO) almost every November like premier wines. But, with 2020-2021 not a year like any other, the new guidelines were instead published in February, entering into force on 1 March. Sylvain Chaffraix sets out the changes.
When carrying out prior art searches, it’s important not to confuse the objective of patentability with that of freedom to operate. Vincent Robert explains the distinction.
Many of the world’s best known or most life-changing inventions were discovered entirely by chance. Valérie Stephann sets out five serendipitous discoveries.
Article 53(a) of the European Patent Convention (EPC) stipulates that European patents are not to be granted for inventions where commercial use would be contrary to public order or morality. Stéphanie Landais-Patarin discusses a recent case that considered such a decision in the context of animal cruelty.
It is important to register any changes that affect the life of a patent or patent application with the relevant patent office(s). However, the requirements for updating a title – or consequences of not doing so – can differ dramatically, depending on the type of change and country, as Rose-Marie Ehanno and Paul Rolland explain.